HALOZYME THERAPEUTICS INC shareholders Q2 2023

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 369 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.

HALOZYME THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
NVWM, LLC 293$10,5690.00%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 19,674$7100.00%
Skandinaviska Enskilda Banken AB (publ) 11,087$4000.00%
DEUTSCHE BANK AG\ 155,975$5,626,0180.00%
CITIGROUP INC 128,447$4,633,0830.00%
CI INVESTMENTS INC. 11,531$4160.00%
VAN ECK ASSOCIATES CORP 20,823$7510.00%
UNITED CAPITAL FINANCIAL ADVISORS, LLC 7,639$275,5390.00%
ENVESTNET ASSET MANAGEMENT INC 142,145$5,127,1700.00%
NISA INVESTMENT ADVISORS, LLC 5,874$211,8750.00%
FIFTH THIRD BANCORP 11,954$431,1810.00%
Renaissance Technologies 34,080$1,2290.00%
Front Row Advisors LLC 134$50.00%
JANE STREET GROUP, LLC 173,252$6,249,2000.00%
Tortoise Investment Management, LLC 300$10,8210.00%
PEAK6 Investments LLC 13,000$468,9100.00%
HSBC HOLDINGS PLC 58,058$2,095,3630.00%
MONTAG A & ASSOCIATES INC 750$27,0530.00%
AVIVA PLC 13,505$487,1250.00%
Lee Financial Co 320$11,5430.00%
External links

This page lists HALOZYME THERAPEUTICS INC's shareholders in Q2 2023. To view HALOZYME THERAPEUTICS INC's shareholder history, click here.